Walgreens Boots Alliance, Inc. (NASDAQ:WBA) had its target price decreased by investment analysts at Citigroup Inc. from $95.00 to $81.00 in a report released on Thursday. The firm currently has a “buy” rating on the pharmacy operator’s stock. Citigroup Inc.’s target price indicates a potential upside of 22.23% from the stock’s current price.

WBA has been the topic of several other research reports. Jefferies Group LLC set a $93.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday. Needham & Company LLC restated a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, October 5th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Finally, Leerink Swann set a $86.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Friday, July 7th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the company. Walgreens Boots Alliance has an average rating of “Buy” and a consensus target price of $87.63.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter last year, the company posted $1.07 earnings per share. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock buyback plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/11/02/walgreens-boots-alliance-inc-wba-given-new-81-00-price-target-at-citigroup-inc.html.

In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 13.50% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently modified their holdings of WBA. Hudock Capital Group LLC lifted its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares in the last quarter. Modera Wealth Management LLC lifted its stake in Walgreens Boots Alliance by 0.4% in the 1st quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock valued at $204,000 after acquiring an additional 9 shares in the last quarter. Flagship Harbor Advisors LLC lifted its stake in Walgreens Boots Alliance by 0.5% in the 1st quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after acquiring an additional 16 shares in the last quarter. Sowell Financial Services LLC lifted its stake in Walgreens Boots Alliance by 0.6% in the 1st quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock valued at $218,000 after acquiring an additional 17 shares in the last quarter. Finally, WealthTrust Arizona LLC lifted its stake in Walgreens Boots Alliance by 0.4% in the 2nd quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock valued at $412,000 after acquiring an additional 21 shares in the last quarter. Institutional investors and hedge funds own 60.24% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.